NHS trials

‘Exciting’ skin cancer vaccine halves risk of relapse or death in study

by
‘Exciting’ skin cancer vaccine halves risk of relapse or death in study

A cutting-edge skin cancer vaccine being trialled on NHS patients halves the risk of death or relapse, a study found. Given after surgery, the jab is custom built in a matter of weeks to target each patient’s specific cancer mutations. The largest trial to date found it cut the chances of relapse or death for … Read more

Thousands to get cutting-edge personalised cancer vaccines in NHS trials

by
Thousands to get cutting-edge personalised cancer vaccines in NHS trials

Elliot Pfebve was the first patient to received a pioneering bowel cancer vaccine (Image: NHS) A cancer vaccine revolution will see thousands of NHS patients receive cutting-edge treatments personalised to their tumours in the hope of boosting cure rates. Given after surgery and chemotherapy, the vaccines aim to destroy any lingering tumour cells and slash … Read more